http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2464984-C2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e245559d2ef02587585552747a7c7d24
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5415
filingDate 2007-11-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2012-10-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_72def64cd5e2657ebf6be665f6ede4cd
publicationDate 2012-10-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2464984-C2
titleOfInvention Non-steroid anti-inflammatory drug
abstract FIELD: medicine, pharmaceutics. n SUBSTANCE: invention refers to pharmaceutical industry. The drug contains meloxicam as an active substance, and sodium chloride, glycine, glycofurol (tetraglycol), poloxamer (lutrol), methyl glucamine, sodium hydroxide and water for injections in the amounts specified in the patent claim. The relation of glycofurol and poloxamer makes 2:1. n EFFECT: invention provides preparing a new dosage form of meloxicam - a solution for intramuscular introduction in the integrated treatment of arthropathies accompanied by pain syndrome.
priorityDate 2007-11-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2238733-C2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2283112-C1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2260432-C1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID152743321
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419493418
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415814097
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID110717
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425165937
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID32170
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54677470
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID174
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454671007
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8200
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24906312
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5816
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8567
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419551195
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419537453
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454185321
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6019
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5234
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419588607
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID137319715
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID447683085
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451052435
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448670727
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419502931
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14798
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4583
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22483
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID417430547
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6042
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID750
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419515558
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419572113
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415136092
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409060395

Total number of triples: 53.